Effect of Metformin on Stem Cells: Molecular Mechanism and Clinical Prospect
Overview
Authors
Affiliations
Metformin is a first-line medication for type II diabetes. Numerous studies have shown that metformin not only has hypoglycemic effects, but also modulates many physiological and pathological processes ranging from aging and cancer to fracture healing. During these different physiological activities and pathological changes, stem cells usually play a core role. Thus, many studies have investigated the effects of metformin on stem cells. Metformin affects cell differentiation and has promising applications in stem cell medicine. It exerts anti-aging effects and can be applied to gerontology and regenerative medicine. The potential anti-cancer stem cell effect of metformin indicates that it can be an adjuvant therapy for cancers. Furthermore, metformin has beneficial effects against many other diseases including cardiovascular and autoimmune diseases. In this review, we summarize the effects of metformin on stem cells and provide an overview of its molecular mechanisms and clinical prospects.
Nabavizadeh S, Shadi M, Khorraminejad-Shirazi M, Daneshi S, Tavanafar S, Naseri R J Maxillofac Oral Surg. 2024; 23(6):1391-1404.
PMID: 39618445 PMC: 11607265. DOI: 10.1007/s12663-023-02094-0.
Sadeghsoltani F, Biray Avci C, Hassanpour P, Haiaty S, Rahmati M, Mota A Stem Cell Res Ther. 2024; 15(1):189.
PMID: 38956646 PMC: 11218273. DOI: 10.1186/s13287-024-03813-1.
Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review.
Dixon S, Oconnor A, Brooks-Noreiga C, Clark M, Levy A, Castejon A Cancer Chemother Pharmacol. 2024; 94(1):1-23.
PMID: 38914751 DOI: 10.1007/s00280-024-04686-0.
Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs.
Greco A, Coperchini F, Croce L, Magri F, Teliti M, Rotondi M Front Pharmacol. 2023; 14:1303844.
PMID: 38146457 PMC: 10749369. DOI: 10.3389/fphar.2023.1303844.
Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms.
Wang L, Zhang Z J Diabetes Res. 2023; 2023:4388437.
PMID: 38020199 PMC: 10653978. DOI: 10.1155/2023/4388437.